CHOP
1 product
2 abstracts
Abstract
A multi-institutional prospective cohort study of minimal residual disease in peripheral T-cell lymphoma: Impact of autologous stem cell transplant.Org: Washington University School of Medicine in St Louis, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Invivoscribe, Inc.,
Abstract
ZUMA-22: A phase 3, randomized controlled study of axicabtagene ciloleucel (axi-cel) versus standard-of-care therapy in patients with relapsed or refractory (R/R) follicular lymphoma (FL).Org: Sarah Cannon Research Institute/Tennessee Oncology, Tennessee Oncology, PLLC, Dana-Farber Cancer Institute, MD Anderson Cancer Center, University of Lille,
Product
CHOP + CD4